8-K - bioAffinity Technologies, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

bioAffinity Technologies, Inc. furnished presentation materials dated March 2026 under Item 7.01 as Exhibit 99.1, which management intends to use in presentations about the Company’s operations and performance. The materials were posted to the Company’s website on March 26, 2026, and are not deemed filed under the Exchange Act or incorporated by reference.

Key Takeaways

1Presentation Materials furnished as Exhibit 99.1 under Item 7.01

2Materials posted to Company website on 2026-03-26

3Intended for use in presentations on Company operations and performance

4Exhibit 99.1 not deemed 'filed' under Section 18 of Exchange Act

5Not subject to liabilities of Section 18

6Not incorporated by reference into Securities Act or Exchange Act filings

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

and Exhibit 99.1 of this Current Report on Form 8-K shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the

Regulation Fd

9.01

. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Presentation Materials – March 2026 104 Cover Page Interactive Data File (emb

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1